Cell Death News and Research

RSS

Novel platform can become a potential approach for personalized cancer treatments

Killing cancer cells without affecting surrounding normal cells is the most desirable approach for targeted cancer therapy. However, it cannot be easily achieved due to the similarities in the properties between normal and cancer cells.

22 Feb 2022

Lung microbiome alterations and secondary-infections in lethal COVID-19

Researchers examined how an interplay of host and microbial factors weakened immunity leading to secondary infections in COVID-19-infected individuals.

22 Feb 2022

Study identifies a protein complex critical for regulating apoptosis and necroptosis

Cell death plays an important role in normal human development and health but requires tightly orchestrated balance to avert disease. Too much can trigger a massive inflammatory immune response that damages tissues and organs. Not enough can interfere with the body's ability to fight infection or lead to cancer.

18 Feb 2022

Early antiretroviral therapy is crucial to fight against HIV and latent tuberculosis

Two weeks makes a big difference in treating the animal version of HIV and latent tuberculosis, researchers from Texas Biomedical Research Institute, Southwest National Primate Research Center and colleagues report this month in the Journal of Clinical Investigation.

18 Feb 2022

The long-term consequences of SARS-CoV-2 infection in people with HIV

In a recent study posted to the medRxiv* preprint server, an interdisciplinary team of researchers from the United States (US) analyzed a cohort of patients with human immunodeficiency virus (HIV) (PWH) recovering from coronavirus disease 2019 (COVID-19) and characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific immune responses in these patients.

15 Feb 2022

Study investigates whether SARS-CoV-2 infection is associated with increased risk of incident type 1 diabetes

A recent study has demonstrated that although the incidence of type 1 diabetes increases among children during the COVID-19 pandemic, previous infection by SARS-CoV-2 does not directly act as a causal factor.

15 Feb 2022

Progression of Alzheimer's disease is linked to oxidative brain damage, research confirms

Increased oxidative damage is linked to neurodegenerative disorders such as Alzheimer's disease (AD). Even though the pathophysiology of AD has been widely investigated, the likely relationship between mitochondrial dysfunction and the disease remains largely unknown.

14 Feb 2022

Researchers identify autoantibody targets in COVID-19 patients

In a new study, researchers have been investigating auto-immune responses to natural human antigens in COVID-19 patients.

14 Feb 2022

Scientists discover a new class of potential drug targets for neurodegenerative diseases

Oregon State University scientists have discovered a new class of potential drug targets for people suffering from neurodegenerative conditions such as Alzheimer's, Parkinson's and Lou Gehrig's disease.

10 Feb 2022

Research reveals a possible strategy to prevent B-cell acute lymphoblastic leukemia

Short-term treatment with the drug ruxolitinib prevents B-cell acute lymphoblastic leukemia (B-ALL) in mice that have a genetic predisposition to the disease.

8 Feb 2022

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

A new article reviewed the innate immune detection and signaling pathways that the host uses against SARS-CoV-2.

7 Feb 2022

Researchers investigate how messenger substances signal inflammation during damaged cell removal

A research team from Cologne and Osnabrück has investigated in detail how messenger substances signal inflammation during the removal of damaged cells in the body.

4 Feb 2022

SARS-CoV-2 entry at the cell surface facilitated by trypsin

Exogenous trypsin treatment boosts SARS-CoV-2 infection in Vero E6 cells and promotes viral multiplication in cultured cells.

1 Feb 2022

Combined strategy suppresses the growth of deadly brain tumor

Short bursts of radiation therapy dramatically enhanced the efficiency of targeting glioblastomas with natural nanoparticle-based immunotherapy, thus suppressing growth of the deadly tumor, inducing anti-tumor immunity and prolonging survival in animal models, a research team at Massachusetts General Hospital has discovered.

31 Jan 2022

Cell Death News and Research

Novel platform can become a potential approach for personalized cancer treatments

Lung microbiome alterations and secondary-infections in lethal COVID-19

Study identifies a protein complex critical for regulating apoptosis and necroptosis

Early antiretroviral therapy is crucial to fight against HIV and latent tuberculosis

The long-term consequences of SARS-CoV-2 infection in people with HIV

Study investigates whether SARS-CoV-2 infection is associated with increased risk of incident type 1 diabetes

Progression of Alzheimer's disease is linked to oxidative brain damage, research confirms

Researchers identify autoantibody targets in COVID-19 patients

Scientists discover a new class of potential drug targets for neurodegenerative diseases

Research reveals a possible strategy to prevent B-cell acute lymphoblastic leukemia

Innate immune processes involved in SARS-CoV-2 recognition and resultant inflammation

Researchers investigate how messenger substances signal inflammation during damaged cell removal

SARS-CoV-2 entry at the cell surface facilitated by trypsin

Combined strategy suppresses the growth of deadly brain tumor

Drugs derived from activated protein C may limit ischemia and reperfusion injury, study suggests

Imaging microscopy shows killer T-cells targeting SARS-CoV-2 spike protein

Damon Runyon Cancer Research Foundation announces newest cohort of Fellows and Breakthrough Scientists

Research opens up new avenues for cancer treatment

Immuno-proteomic profiling suggests aberrant immune cell regulation associated with post-COVD-19 infection

Impact of DNA clearance on mortality in patients with severe COVID-19 infections

Event Guide: 3rd Annual TRP Supply Chain & Manufacturing Summit eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics